Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR | 0000201772-22-000002 | Mar 31st, 2022 12:00AM | May 9th, 2022 12:00AM | May 9th, 2022 12:00AM | ESSEX INVESTMENT MANAGEMENT CO LLC | 201772 | SOCIETAL CDMO INC COM | COM | 75629F109 | 1440 | 799841 | SH | SOLE | 360020 | 0 | 439821 | May 10th, 2022 01:24AM | May 10th, 2022 01:24AM | Recro Pharma | Pharmaceuticals & Biotechnology | |||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR | 0000950123-22-000377 | Dec 31st, 2021 12:00AM | Jan 21st, 2022 12:00AM | Jan 21st, 2022 12:00AM | Russell Investments Group, Ltd. | 1692234 | Recro Pharma Inc | Common Stock | 75629F109 | 284 | 166333 | SH | SOLE | 46 | 166333 | 0 | 0 | May 6th, 2022 06:58AM | May 6th, 2022 06:58AM | Recro Pharma | Pharmaceuticals & Biotechnology | ||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR | 0000950123-22-000377 | Dec 31st, 2021 12:00AM | Jan 21st, 2022 12:00AM | Jan 21st, 2022 12:00AM | Russell Investments Group, Ltd. | 1692234 | Recro Pharma Inc | Common Stock | 75629F109 | 439 | 257090 | SH | DFND | 12 | 0 | 0 | 257090 | May 6th, 2022 06:58AM | May 6th, 2022 06:58AM | Recro Pharma | Pharmaceuticals & Biotechnology | ||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR/A | 0000769993-22-000005 | Sep 30th, 2021 12:00AM | Jan 20th, 2022 12:00AM | Jan 20th, 2022 12:00AM | GOLDMAN SACHS GROUP INC | 886982 | RECRO PHARMA INC | CMN | 75629F109 | 36 | 17364 | SH | DFND | 2 | 17364 | 0 | 0 | May 6th, 2022 06:52AM | May 6th, 2022 06:52AM | Recro Pharma | Pharmaceuticals & Biotechnology | ||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR/A | 0000769993-22-000005 | Sep 30th, 2021 12:00AM | Jan 20th, 2022 12:00AM | Jan 20th, 2022 12:00AM | GOLDMAN SACHS GROUP INC | 886982 | RECRO PHARMA INC | CMN | 75629F109 | 61 | 29531 | SH | DFND | 1 | 29506 | 0 | 25 | May 6th, 2022 06:52AM | May 6th, 2022 06:52AM | Recro Pharma | Pharmaceuticals & Biotechnology | ||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR | 0000950123-22-004585 | Mar 31st, 2022 12:00AM | May 5th, 2022 12:00AM | May 5th, 2022 12:00AM | Russell Investments Group, Ltd. | 1692234 | Societal CDMO Inc | Common Stock | 75629F109 | 78 | 43636 | SH | DFND | 43636 | 0 | 0 | May 6th, 2022 01:46AM | May 6th, 2022 01:46AM | Recro Pharma | Pharmaceuticals & Biotechnology | |||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR | 0000950123-22-004585 | Mar 31st, 2022 12:00AM | May 5th, 2022 12:00AM | May 5th, 2022 12:00AM | Russell Investments Group, Ltd. | 1692234 | Societal CDMO Inc | Common Stock | 75629F109 | 802 | 445887 | SH | DFND | 445887 | 0 | 0 | May 6th, 2022 01:46AM | May 6th, 2022 01:46AM | Recro Pharma | Pharmaceuticals & Biotechnology | |||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR | 0000950123-22-004585 | Mar 31st, 2022 12:00AM | May 5th, 2022 12:00AM | May 5th, 2022 12:00AM | Russell Investments Group, Ltd. | 1692234 | Societal CDMO Inc | Common Stock | 75629F109 | 202 | 112426 | SH | SOLE | 42 | 112426 | 0 | 0 | May 6th, 2022 01:46AM | May 6th, 2022 01:46AM | Recro Pharma | Pharmaceuticals & Biotechnology | ||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR | 0000950123-22-004585 | Mar 31st, 2022 12:00AM | May 5th, 2022 12:00AM | May 5th, 2022 12:00AM | Russell Investments Group, Ltd. | 1692234 | Societal CDMO Inc | Common Stock | 75629F109 | 462 | 257090 | SH | DFND | 12 | 0 | 0 | 257090 | May 6th, 2022 01:46AM | May 6th, 2022 01:46AM | Recro Pharma | Pharmaceuticals & Biotechnology | ||
nasdaq:reph | nasdaq:reph Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | RECRO PHARMA INC | COM | 75629F109 | 238 | 33443 | SH | DFND | 33443 | 0 | 0 | May 5th, 2022 07:59AM | May 5th, 2022 07:59AM | Recro Pharma | Pharmaceuticals & Biotechnology |